APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
STONY BROOK, N.Y. – July 18, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced the participation of LineaRx, Inc., its majority-owned biotherapeutics subsidiary, in upcoming mRNA industry conferences in Boston: July 26 – 28, the mRNA-Based Therapeutics Summit at the Boston Convention and Exhibition [...]